Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix,...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of AURX is 3.0 and suggests 88% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell